SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) July 2, 1997
BOSTON BIOMEDICA, INC.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Exact Name of Registrant as Specified in Its Charter)
Massachusetts 0-21615 04-2652826
. . . . . . . . . . . . . . . . . . . . . . . . . . .
(State or Other (Commission (I.R.S. Employer
Jurisdiction File Number) Identification No.)
of Incorporation)
375 West Street, West Bridgewater, Massachusetts 02379
. . . . . . . . . . . . . . . . . . . . . . . . . . .
(Address of Principal Executive Offices) (Zip Code)
(508) 580-1900
Registrant's telephone number, including area code . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . .
(Former Name or Former Address, If Changed Since Last Report)
Total number of pages:___
Exhibit index at page: 3
ITEM 2. ACQUISITION OF ASSETS
On July 2, 1997, the Registrant acquired, through BBI-Source
Scientific, Inc., a Massachusetts corporation and wholly owned subsidiary of the
Registrant, substantially all of the properties, assets, business and certain
liabilities of Source Scientific, Inc., a California corporation ("Source
Scientific"), for an aggregate cash purchase price of approximately $1,894,000.
The purchase price paid in connection with the acquisition was based on a
determination by the Board of Directors of the Registrant as to the fair market
value of the business of Source Scientific. The Registrant funded the
acquisition through its existing resources. Source Scientific is engaged in the
business of designing, manufacturing and marketing devices used in hospital,
clinical and analytical laboratories, and is based in Garden Grove, California.
The Registrant intends to retain the existing management team, facility and
employees of Source Scientific.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(a) Financial Statements of Business Acquired and Pro Forma Financial
Information.
------------------------------------------------------------------
None.
(b) Exhibits.
Exhibit No. Description of Exhibit
----------- ----------------------
2 Asset Purchase Agreement
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BOSTON BIOMEDICA, INC.
Date: July 17, 1997 By: /s/ Kevin W. Quinlan
--------------------
Kevin W. Quinlan, Chief Financial Officer
EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION OF EXHIBIT
2 Asset Purchase Agreement
-2-
EXHIBIT NO. 2
================================================================================
ASSET PURCHASE AGREEMENT
ACQUISITION OF SUBSTANTIALLY ALL OF THE ASSETS OF
SOURCE SCIENTIFIC, INC.
BY
BBI-SOURCE SCIENTIFIC, INC.,
a wholly owned subsidiary
OF
BOSTON BIOMEDICA, INC.
DATED: MARCH 26, 1997
================================================================================
-3-
ASSET PURCHASE AGREEMENT
TABLE OF CONTENTS
Page
----
ARTICLE 1. PURCHASE AND SALE OF ASSETS....................................... 4
1.1 Sale of Assets......................................................... 4
1.2 Assumption of Liabilities.............................................. 4
1.3 Purchase Price and Payment............................................. 6
1.4 Adjustment to Purchase Price........................................... 6
1.5 Time and Place of Closing.............................................. 6
1.6 Delivery of Assumption of Liabilities.................................. 6
1.7 Transfer of Subject Assets............................................. 7
1.8 Delivery of Records and Contracts...................................... 7
1.9 Change of Name......................................................... 7
1.10 Further Assurances.................................................... 7
1.11 Tax Returns........................................................... 8
1.12 Allocation of Purchase Price.......................................... 8
ARTICLE 2. REPRESENTATIONS AND WARRANTIES OF SELLER.......................... 8
2.1 Organization and Qualification of Seller............................... 8
2.2 Capitalization of Seller............................................... 8
2.3 Subsidiaries........................................................... 8
2.4 Authorization of Transaction........................................... 9
2.5 Present Compliance with Obligations and Laws........................... 9
2.6 No Conflict of Transaction With Obligations and Laws................... 9
2.7 Financial Statements...................................................10
2.8 Absence of Undisclosed Liabilities.....................................10
2.9 Absence of Certain Changes.............................................10
2.10 Payment of Taxes......................................................11
2.11 Title to Properties; Liens; Condition of Properties...................12
2.12 Collectibility of Accounts Receivable.................................12
2.13 Inventories...........................................................13
2.14 Intellectual Property Rights..........................................13
2.15 Contracts and Commitments.............................................15
2.16 Labor and Employee Relations..........................................16
2.17 Employee Benefits and ERISA...........................................16
2.18 Environmental Matters.................................................18
2.19 Permits...............................................................19
2.20 Warranty or Other Claims..............................................20
2.21 Litigation............................................................20
2.22 Borrowings and Guarantees.............................................20
2.23 Financial Service Relations and Powers of Attorney....................20
2.24 Insurance.............................................................20
2.25 Minute Books..........................................................21
-i-
2.26 Finder's Fee..........................................................21
2.27 Transactions with Interested Persons..................................21
2.28 Absence of Sensitive Payments.........................................21
2.29 Disclosure of Material Information....................................21
2.30 SEC Filings...........................................................22
ARTICLE 3. REPRESENTATIONS AND WARRANTIES OF BBI AND BUYER...................22
3.1 Organization of BBI and Buyer..........................................22
3.2 Authorization of Transaction...........................................22
3.3 No Conflict of Transaction With Obligations and Laws...................22
3.4 SEC Filings............................................................23
3.5 Litigation.............................................................24
3.6 Finder's Fee...........................................................24
ARTICLE 4. COVENANTS OF SELLER...............................................24
4.1 Conduct of Business....................................................24
4.2 Authorization from Others..............................................25
4.3 Breach of Representations and Warranties...............................25
4.4 Consummation of Agreement..............................................25
4.5 Compliance with Securities Laws........................................26
ARTICLE 5. COVENANTS OF BBI AND BUYER........................................26
5.1 Authorization from Others..............................................26
5.2 Consummation of Agreement..............................................26
5.3 Disclosure of Adverse Change...........................................26
ARTICLE 6. CONDITIONS TO OBLIGATIONS OF BBI AND BUYER........................26
6.1 Shareholder Authorization..............................................26
6.2 Dissenting Stockholders................................................26
6.3 Representations; Warranties; Covenants.................................27
6.4 No Material Adverse Change.............................................27
6.5 Opinion of Seller's Counsel............................................27
6.6 Employment Contracts...................................................27
6.7 Non-Competition Contracts..............................................27
6.8 Approval of Board of Directors.........................................27
6.9 Approval of Buyer's Counsel............................................28
6.10 Absence of Certain Litigation.........................................28
6.11 FIRPTA Certificate....................................................28
6.12 Consents and Waivers..................................................28
6.13 Escrow Agreement......................................................28
6.14 Convertible Debentures................................................28
6.15 Opinion of Auditors...................................................28
6.16 Opinion of Investment Banking Firm....................................29
6.17 Due Diligence.........................................................29
6.18 Facility Lease........................................................29
6.19 Reduction of Interest Payments........................................29
6.20 Consents to Transactions..............................................29
6.21 Authorization.........................................................29
-ii-
6.22 Bulk Sales Law........................................................29
ARTICLE 7. CONDITIONS TO OBLIGATIONS OF SELLER...............................29
7.1 Shareholder Authorization..............................................30
7.2 Representations; Warranties; Covenants.................................30
ARTICLE 8. TERMINATION OF AGREEMENT..........................................30
8.1 Termination............................................................30
8.2 Right to Proceed.......................................................30
ARTICLE 9. RIGHTS AND OBLIGATIONS SUBSEQUENT TO CLOSING......................30
9.1 Survival of Warranties.................................................30
9.2 Collection of Assets...................................................30
9.3 Payment of Debts.......................................................31
ARTICLE 10. INDEMNIFICATION..................................................31
10.1 Definitions...........................................................31
10.2 Indemnification by Seller.............................................32
10.3 Indemnification by Buyer..............................................32
10.4 Defense of Third Party Actions........................................33
10.5 Miscellaneous.........................................................34
10.6 Payment of Indemnification............................................34
ARTICLE 11. MISCELLANEOUS....................................................34
11.1 Fees and Expenses....................................................34
11.2 Notices...............................................................34
11.4 Publicity and Disclosures.............................................35
11.5 Non-Solicitation......................................................36
11.6 Confidentiality.......................................................36
11.7 Entire Agreement......................................................36
11.8 Severability..........................................................36
11.9 Assignability.........................................................36
11.10 Amendment............................................................36
11.11 Attorney-in-Fact.....................................................36
11.12 Governing Law; Venue.................................................36
11.13 Counterparts.........................................................37
11.14 Effect of Table of Contents and Headings............................37
-iii-
ASSET PURCHASE AGREEMENT
AGREEMENT entered into as of the 26th day of March, 1997, among Boston
Biomedica, Inc., a Massachusetts corporation with its principal place of
business in West Bridgewater, Massachusetts ("BBI"), BBI-Source Scientific,
Inc., a Massachusetts corporation and wholly owned subsidiary of BBI ("Buyer")
and Source Scientific, Inc., a California corporation with its principal place
of business in Garden Grove, California ("Seller").
RECITALS:
WHEREAS, Buyer wishes to acquire substantially all of the assets of Seller
and assume certain liabilities and obligations of Seller, and Seller wishes to
convey such assets to Buyer, subject to such liabilities and subject to the
terms and conditions set forth in this Agreement;
NOW, THEREFORE, in consideration of the mutual agreements contained herein
and for other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the parties hereto agree as follows:
ARTICLE 1. PURCHASE AND SALE OF ASSETS.
1.1 Sale of Assets.
(a) Subject to the provisions of this Agreement and except as
expressly excluded in paragraph 1.1(b), Seller agrees to sell and Buyer agrees
to purchase, at the Closing (as defined in Section 1.5 hereof), all of the
properties, assets and business of Seller of every kind and description,
tangible and intangible, real, personal or mixed, and wherever located,
including without limitation all assets set forth on Schedule 1.1 hereto, all
assets shown or reflected on the Base Balance Sheet (as defined in Section 2.7
hereof) of Seller and all assets acquired or created by Seller in the ordinary
course of business and consistent with the terms hereof since the date of the
Base Balance Sheet through the Closing, and all of Seller's good will and the
exclusive right to use the name of Seller as all or part of a trade or corporate
name. The assets, property and business of Seller to be sold to and purchased by
Buyer under this Agreement are hereinafter sometimes referred to as the "Subject
Assets."
(b) Seller's corporate franchise, stock record books, corporate
record books containing minutes of meetings of directors and stockholders and
such other records as have to do exclusively with Seller's organization or stock
capitalization shall be excluded from the Subject Assets.
1.2 Assumption of Liabilities.
(a) Upon the sale and purchase of the Subject Assets, except as
excluded in paragraph 1.2(b), Buyer shall assume and agree to pay or discharge
when due the following:
(i) those liabilities of Seller listed on Schedule
1.2(a) hereto, as derived from the Base Balance Sheet;
(ii) liabilities for accrued vacation and unreimbursed
expenses for the employees and to the extent set forth in Schedule 1.2(a); and
(iii) all liabilities and obligations incurred by Seller
in the ordinary course of business and consistent with the terms hereof since
the date of the Base Balance Sheet which are outstanding at the time of the
Closing.
The liabilities to be assumed by Buyer under this Agreement are hereinafter
sometimes referred to as the "Assumed Liabilities."
(b) Except to the extent expressly assumed pursuant to Section
1.2(a) above, Buyer does not assume and shall not be liable for any debt,
obligation, responsibility or liability of the Seller, or any Affiliate (as
defined below), or any claim against any of the foregoing, whether known or
unknown, contingent or absolute, or otherwise. Without limiting the foregoing
sentence, Buyer shall have no responsibility with respect to the following,
whether or not disclosed in the Base Balance Sheet or a Schedule hereto:
(i) liabilities and obligations related to or arising
from any transactions with any officer, director or stockholder of Seller or any
person or organization controlled by, controlling, or under common control with
any of them (an "Affiliate");
(ii) liabilities and obligations for taxes of any kind
resulting from the operation of Seller through the Closing and any liabilities
and obligations for taxes of any kind related to or arising from the transfers
contemplated hereby;
(iii) liabilities and obligations for damage or injury
to person or property based upon events occurring prior to the date of Closing;
(iv) liabilities and obligations to employees of Seller,
whether for accident, disability, or workers compensation insurance or benefits,
benefits under employee benefit plans, back pay, accrued vacation, or
obligations related to or resulting from severance of employment by Seller;
(v) workmen's liens on any of the Subject Assets;
(vi) liabilities incurred by Seller in connection with
this Agreement and the transactions provided for herein, including counsel and
accountant's fees, filing fees and expenses related to Seller's proxy material,
transfer and other taxes, and expenses pertaining to its liquidation or the
performance by Seller of its obligations hereunder;
(vii) liabilities of Seller to its dissenting
stockholders, if any to the extent holders of in excess of one-half percent
(0.5%) of the outstanding shares of capital stock of Seller exercise dissenting
stockholder rights under the California General Corporation Law; and
(viii) liabilities of Seller with respect to any
options, warrants, agreements or convertible or other rights to acquire any
shares of its capital stock of any class.
(c) The assumption of Assumed Liabilities by Buyer hereunder
shall be treated as independent of Buyer's existing business and shall not
enlarge any rights of third parties under
contracts or arrangements with Buyer or Seller or any of their respective
subsidiaries. Nothing herein shall prevent Buyer from contesting in good faith
any of the Assumed Liabilities.
1.3 Purchase Price and Payment. In consideration of the sale by Seller
to Buyer of the Subject Assets, in addition to the assumption by Buyer of the
Assumed Liabilities, Buyer agrees to pay to Seller and to the Escrow Agent, as
provided hereafter, the aggregate amount of Two Million One Hundred Forty-Four
Thousand Dollars ($2,144,000) (the "Purchase Price"), subject to adjustment as
provided for in Section 1.4 of this Agreement, which shall be payable as
follows:
(a) the sum of One Million Eight Hundred Ninety-Four Dollars
($1,894,000) shall be paid at the Closing to Seller in cash, by certified check
or by federal funds wire transfer; and
(b) the sum of Two Hundred Fifty Thousand Dollars ($250,000.00)
in cash, shall be deposited at the Closing into an interest bearing escrow
account, and held pursuant to an Escrow Agreement, in substantially the form
attached hereto as Exhibit 1.3 (the "Escrow Agreement").
1.4 Adjustment to Purchase Price. The Purchase Price shall be reduced
by One Dollar ($1.00) for each One Dollar ($1.00) that Seller's tangible book
value as of the Closing Date, in accordance with generally accepted accounting
principles, is less than Five Hundred Thousand Dollars ($500,000). Tangible book
value shall be determined by Seller to be Seller's stockholders' equity minus
all intangible assets and is subject to verification by Buyer or, at the option
of Buyer, by Buyer's independent accountants, Coopers & Lybrand L.L.P. ("Coopers
& Lybrand") through an audit or certain procedures as determined by Buyer. Buyer
shall furnish to Seller, for Seller's review and comment, the results of any
audit or procedures performed by Coopers & Lybrand. Any results from Coopers &
Lybrand shall be final and binding on the parties hereto. In the event the
Purchase Price is reduced as provided herein, the amounts of the reduction in
the Purchase Price shall be paid to the Buyer out of the funds held in escrow
pursuant to the Escrow Agreement to the extent of the balance thereof, and shall
then be paid by the Seller. Any amount payable to Buyer as a result of a
Purchase Price adjustment shall be paid to Buyer within five business days of
notice to Seller either of Buyer's verification of Seller's calculation of
Seller's tangible book value or of Coopers & Lybrand's results of audit or
certain procedures performed in assessing the accuracy of Seller's calculation
of Seller's tangible book value as of the Closing Date.
1.5 Time and Place of Closing. The closing of the purchase and sale
provided for in this Agreement (herein called the "Closing") will be held at the
offices of Brown, Rudnick, Freed & Gesmer, counsel to the Buyer, at its offices
at One Financial Center, Boston, Massachusetts on or before May 5, 1997 (the
"Closing Date") or at such other place, date or time as may be fixed by mutual
agreement of the parties.
1.6 Delivery of Assumption of Liabilities. At the Closing, Buyer shall
deliver or cause to be delivered to Seller, among other things, an agreement to
assume the Assumed Liabilities having substantially the provisions of Section
1.2 hereof and in substantially the form set forth as Exhibit 1.6 hereto.
1.7 Transfer of Subject Assets. At the Closing, Seller shall deliver or
cause to be delivered to Buyer good and sufficient instruments of transfer
transferring to Buyer title to all the
Subject Assets including a Bill of Sale in substantially the form set forth as
Exhibit 1.7 hereto, and such other instruments of transfer as Buyer may require.
Such instruments of transfer (a) shall be in the form and will contain the
warranties, covenants and other provisions (not inconsistent with the provisions
hereof) which are usual and customary for transferring the type of property
involved under the laws of the jurisdictions applicable to such transfers, (b)
shall be in form and substance satisfactory to counsel for Buyer, and (c) shall
effectively vest in Buyer good and marketable title to all the Subject Assets,
free and clear of all liens, restrictions and encumbrances except those
specifically disclosed in the Schedule hereto or in the Base Balance Sheet and
which Buyer has agreed herein may remain in place at and after Closing.
1.8 Delivery of Records and Contracts. At the Closing, Seller shall
deliver or cause to be delivered to Buyer all of Seller's leases, contracts,
commitments and rights, with such assignments thereof and consents to
assignments as are necessary to assure Buyer of the full benefit of the same.
Seller shall also deliver to Buyer at the Closing all of Seller's business
records, tax returns, books and other data relating to its assets, business and
operations (except corporate records and other property of Seller excluded under
Subsection 1.1(b)) and Seller shall take all requisite steps to put Buyer in
actual possession and operating control of the Subject Assets and business of
Seller. After the Closing, Buyer shall afford to Seller and its accountants and
attorneys reasonable access to the books and records of Seller delivered to
Buyer under this Section 1.8 and shall permit Seller to make extracts and copies
therefrom for the purpose of preparing such tax returns of Seller as may be
required after the Closing and for other proper purposes approved by Buyer.
1.9 Change of Name. Immediately following the Closing, Seller shall
file with the California Secretary of State an amendment to its Charter (as
hereafter defined) changing its name to a name which does not include the words
"Source Scientific." At the Closing, Seller shall deliver to the Buyer a consent
in form satisfactory to the Secretary of State of Massachusetts consenting to
the use of the name "Source Scientific" by Buyer or any affiliate thereof.
1.10 Further Assurances. Seller from time to time after the Closing at
the request of Buyer and without further consideration shall execute and deliver
further instruments of transfer and assignment (in addition to those delivered
under Section 1.7) and take such other action as Buyer may reasonably require to
more effectively transfer and assign to, and vest in, Buyer all of its right,
title and interest in and to the Subject Assets free and clear of all liens and
encumbrances, except those expressly permitted hereby. To the extent that the
assignment of any lease, contract, commitment or right shall require the consent
of other parties thereto, this Agreement shall not constitute an assignment
thereof; however, Seller shall obtain before the Closing any necessary consents
or waivers to assure Buyer of the benefits of such leases, contracts,
commitments or rights. Seller shall cooperate with Buyer to permit Buyer to
enjoy Seller's rating and benefits under the workman's compensation laws and
unemployment compensation laws of applicable jurisdictions, to the extent
permitted by such laws. Nothing herein shall be deemed a waiver by Buyer of its
right to receive at the Closing an effective assignment of each of the leases,
contracts, commitments or rights of Seller.
1.11 Tax Returns. Seller, with the assistance and approval of Buyer,
shall promptly prepare and file on or before the due date or any extension
thereof (together with Buyer's payment for the amount of taxes, if any, shown to
be due thereon which constitute Assumed Liabilities) all required federal, state
and local tax returns with respect to Seller's operations prior
to the Closing. Unless Buyer otherwise requests, Seller shall also take all
necessary steps to terminate its fiscal year for federal income tax purposes on
the Closing date.
1.12 Allocation of Purchase Price. The purchase price payable by Buyer
for the Subject Assets pursuant to Section 1.3 and the face amount of the
Assumed Liabilities assumed pursuant to Section 1.2 shall represent payment for
the Subject Assets at the prices shown on a memorandum to be prepared and
initialed by the parties and delivered at the Closing or as soon thereafter as
required information is made available. The prices reflected in said memorandum
shall represent the fair market values of the Subject Assets at the Closing, to
the best of the knowledge and belief of the parties hereto, and the parties
hereto agree that they will not take a position inconsistent with such
allocation for Federal income tax purposes.
ARTICLE 2. REPRESENTATIONS AND WARRANTIES OF SELLER.
Seller hereby represents and warrants to Buyer as follows:
2.1 Organization and Qualification of Seller. Seller is a corporation
duly organized, validly existing and in good standing under the laws of the
State of California, with full power and authority to own or lease its
properties and to conduct its business in the manner and in the places where
such properties are owned or leased or such business is conducted by it. The
copies of Seller's Certificate of Incorporation or equivalent document as
amended to date ("Charter"), certified by the California Secretary of State, and
of Seller's by-laws as amended to date, certified by Seller's Secretary (or the
equivalent), and previously delivered to Buyer's counsel, are complete and
correct. Seller is duly qualified to do business as a foreign corporation in
every jurisdiction in which such qualification is required. The states in which
Seller is so qualified are listed on Schedule 2.1.
2.2 Capitalization of Seller. The authorized capital stock of the
Seller consists of 75,000,000 shares of common stock, no par value (the "Common
Stock"), of which 34,540,004 shares are validly issued and outstanding, fully
paid and non-assessable as of the date of this Agreement. Except as set forth on
Schedule 2.2 hereto, there are no (a) outstanding warrants, options or other
rights granted by Seller or, to Seller's knowledge, by any principal
stockholders of Seller (the "Principal Stockholders"), to purchase or acquire,
or pre-emptive rights with respect to the issuance or sale of, the capital stock
of Seller, (b) other securities of Seller directly or indirectly convertible
into or exchangeable for shares of capital stock of the Seller, or (c)
restrictions on the transfer of Seller's capital stock. For purposes of this
Agreement, Principal Stockholders shall include all stockholders of Seller who
hold, of record or beneficially, five percent (5%) or more of the outstanding
shares of Seller's Common Stock.
2.3 Subsidiaries.
(a) Seller directly or indirectly owns the indicated amounts of
the issued and outstanding capital stock of the corporations listed on Schedule
2.3 to this Agreement (hereinafter referred to as the "Subsidiaries" or
individually as a "Subsidiary"). The Seller has good and marketable title to the
shares of stock of each of the Subsidiaries which it owns, free of any adverse
claim, lien or restriction, and there are no outstanding options, warrants or
other rights of any kind to acquire any additional shares of stock of any of the
Subsidiaries.
(b) Except as set forth on Schedule 2.3, each Subsidiary is a
corporation duly organized, validly existing and in good standing under the laws
of its state of incorporation, with full power and authority to own or lease its
properties and to conduct its business in the manner and in the places where
such properties are owned or leased or such business is conducted. The copies of
the Charter and by-laws of each Subsidiary as amended to date, certified by the
Secretary of State of the state of incorporation of such Subsidiary or its
Secretary (or the equivalent) and previously delivered to Buyer's counsel are
complete and correct. Each of the Subsidiaries is duly qualified to do business
as a foreign corporation in every jurisdiction in which such qualification is
required.
(c) Except as set forth on Schedule 2.3, neither Seller nor any
of its Subsidiaries owns any securities issued by any other business
organization or governmental authority, except U.S. Government securities.
Neither Seller nor any of the Subsidiaries is a partner or participant in any
joint venture or partnership of any kind.
2.4 Authorization of Transaction. All necessary action, corporate or
otherwise, has been taken by Seller and the Stockholders, if any such action is
necessary, to authorize the execution, delivery and performance of this
Agreement and the transactions contemplated hereby, and the Agreement is the
valid and binding obligation of Seller, enforceable in accordance with its
terms.
2.5 Present Compliance with Obligations and Laws. Neither Seller nor
any Subsidiary is: (a) in violation of its Charter or by-laws; (b) in default in
the performance of any material obligation, agreement or condition of any
material debt instrument which (with or without the passage of time or the
giving of notice) affords to any person the right to accelerate any material
indebtedness or terminate any material right; (c) in default or breach of (with
or without the passage of time or the giving of notice) any other material
contract to which it is a party or by which it or any of the Subject Assets are
bound except as disclosed in Schedule 2.21; or (d) in violation of any law,
regulation, administrative order or judicial order applicable to it or its
business or the Subject Assets.
2.6 No Conflict of Transaction With Obligations and Laws.
(a) Neither the execution, delivery or performance of this
Agreement, nor the performance of the transactions contemplated hereby, will:
(i) constitute a breach or violation of the Charter or by-laws of Seller or any
Subsidiary; (ii) conflict with or constitute (with or without the passage of
time or the giving of notice) a breach of, or default under, any debt instrument
to which Seller or any Subsidiary is a party, or give any person the right to
accelerate any material indebtedness or terminate any material right; (iii)
constitute (with or without the passage of time or giving of notice) a default
under or breach of any other material agreement, instrument or obligation to
which Seller or any Subsidiary is a party or by which it or any of the Subject
Assets are bound; or (iv) result in a violation of any law, regulation,
administrative order or judicial order applicable to Seller or any Subsidiary,
or their businesses or the Subject Assets.
(b) The execution, delivery and performance of this Agreement
and the transactions contemplated hereby by the Seller do not require the
consent, waiver, approval, authorization, exemption of or giving of notice to
any governmental authority.
2.7 Financial Statements. Attached as Schedule 2.7 hereto are the
following audited consolidated financial statements of Seller and its
Subsidiaries and unconsolidated statements of such companies for the fiscal
years ended June 30, 1996 and 1995 and unaudited consolidated financial
statements for the six and three month periods ended December 31, 1996 all of
which statements are complete and correct and fairly present the financial
position of Seller and its Subsidiaries on a consolidated or unconsolidated
basis, as the case may be, on the date of such statements and the results of
their operations on the applicable basis for the periods covered thereby, and
such financial statements have been prepared in accordance with generally
accepted accounting principles consistently applied throughout the periods
involved and prior periods.
The Seller's unaudited balance sheet as of December 31, 1996 included
in the above financial statements is sometimes referred to hereinafter as the
"Base Balance Sheet."
2.8 Absence of Undisclosed Liabilities. As of the date of the Base
Balance Sheet, Seller and its Subsidiaries had no material liabilities of any
nature, whether accrued, absolute, contingent or otherwise (including without
limitation liabilities as guarantor or otherwise with respect to obligations of
others, or liabilities for taxes due or then accrued or to become due), except:
(a) the Assumed Liabilities; (b) liabilities stated or adequately reserved
against on the Base Balance Sheet; and (c) liabilities disclosed in Schedule 2.8
hereto. Since the date of the Base Balance Sheet, Seller and its Subsidiaries
had no material liabilities of any nature, whether accrued, absolute, contingent
or otherwise (including without limitation liabilities as guarantor or otherwise
with respect to obligations of others, or liabilities for taxes due or then
accrued or to become due) except (a) the Assumed Liabilities; (b) liabilities
stated or adequately reserved against on the Base Balance Sheet; (c) liabilities
in the aggregate not in excess of [$5,000] arising in the ordinary course of
business; and (d) liabilities disclosed in Schedule 2.8 hereto. There is no fact
which materially adversely affects, or may in the future (so far as can now be
reasonably foreseen) materially adversely affect, the business, properties,
operations or condition of Seller and its Subsidiaries on a consolidated basis
which has not been specifically disclosed herein or in a schedule furnished
herewith.
2.9 Absence of Certain Changes. Except as disclosed in Schedule 2.9
hereto, since the date of the Base Balance Sheet there has not been:
(a) any change in the financial condition, properties, assets,
liabilities, business or operations of the Seller or any Subsidiary which change
by itself or in conjunction with all other such changes, whether or not arising
in the ordinary course of business, has been materially adverse with respect to
Seller or any Subsidiary;
(b) any contingent liability incurred by Seller or any Subsidiary
as guarantor or otherwise with respect to the obligations of others;
(c) any mortgage, encumbrance or lien placed on any of the
properties of Seller or any Subsidiary which remains in existence on the date
hereof or at the time of Closing;
(d) any obligation or liability incurred by Seller or any
Subsidiary other than obligations and liabilities incurred in the ordinary
course of business;
(e) any purchase, sale or other disposition, or any agreement or
other arrangement for the purchase, sale or other disposition, of any of the
properties or assets of Seller
or any Subsidiary other than in the ordinary course of business;
(f) any damage, destruction or loss, whether or not covered by
insurance, materially and adversely affecting the properties, assets or business
of Seller and its Subsidiaries on a consolidated basis;
(g) any declaration, setting aside or payment of any dividend on,
or the making of any other distribution in respect of, the capital stock of
Seller, or any Subsidiary other than a wholly-owned Subsidiary, or any direct or
indirect redemption, purchase or other acquisition by Seller of its own capital
stock or the stock of any such Subsidiary;
(h) any labor trouble or claim of unfair labor practices involving
Seller or any Subsidiary; any change in the compensation payable or to become
payable by Seller or any Subsidiary to any of their officers, employees or
agents other than normal merit increases in accordance with compensation
programs existing on the date of the Base Balance Sheet, or any bonus payment or
arrangement made to or with any of such officers, employees or agents;
(i) any change with respect to the management or supervisory
personnel of Seller or any Subsidiary;
(j) any payment or discharge of a material lien or liability of
Seller or any Subsidiary which was not shown on the Base Balance Sheet or
incurred in the ordinary course of business thereafter; or
(k) any obligation or liability incurred by Seller or any
Subsidiary to any of their employees, officers, directors or shareholders or any
loans or advances made by Seller or any Subsidiary to any of their employees,
officers, directors or shareholders, except transactions between Seller and a
Subsidiary and normal compensation and expense allowances payable to officers.
2.10 Payment of Taxes. Except as disclosed on Schedule 2.10 hereto, the
Seller and each of its Subsidiaries have filed all federal, state, local, and
foreign government income, excise and franchise tax returns, real estate and
personal property tax returns, sales and use tax returns and all other tax
returns required to be filed by them, and they have paid all taxes owing by them
except taxes which have not yet accrued or otherwise become due for which
adequate provision has been made in the pertinent financial statements referred
to in Section 2.7 above. All transfer, excise and other taxes payable to any
jurisdiction by reason of the sale and transfer of the Subject Assets pursuant
to this Agreement shall be paid or provided for by Seller after the Closing out
of the consideration payable by Buyer hereunder. Except as disclosed on Schedule
2.10 hereto, the federal income tax returns of Seller and the Subsidiaries have
never been examined by the Internal Revenue Service and no extension of time for
the assessment of deficiencies for any year is in effect. The provisions for
taxes reflected in the above-mentioned financial statements are adequate to
cover any tax liabilities of Seller and any Subsidiary in respect of their
respective businesses, properties and operations during the periods covered by
said financial statements and all prior periods. Neither the Internal Revenue
Service nor any other taxing authority is now asserting or threatening to assert
against the Seller or any Subsidiary any deficiency or claim for additional
taxes or interest thereon or penalties in connection therewith.
2.11 Title to Properties; Liens; Condition of Properties.
(a) Set forth on Schedule 2.11 hereto is a listing of (i) all
the real property owned by Seller or any Subsidiary at the date hereof, (ii) all
leases under which Seller or any Subsidiary leases real property at the date
hereof, (iii) a complete description of the machinery, equipment and other
personal property used or owned by Seller or any Subsidiary as of the date
hereof, and (iv) all leases under which Seller or any Subsidiary leases any
personal property at the date hereof. Except as specifically disclosed in
Schedule 2.11 or in the Base Balance Sheet, Seller and its Subsidiaries have
good and marketable title in fee simple to all of their real and personal
property, including property described in said schedule as owned, and all of
their leases are valid and subsisting and fully assignable by Seller or its
Subsidiaries (as the case may be) and no default exists under any thereof.
(b) None of the real or personal property owned or used by
Seller or any Subsidiary is subject to any mortgage, pledge, lien (other than
for taxes not yet due and payable), conditional sale agreement, security title,
encumbrance or other charge, except as specifically disclosed in Schedule 2.11
or in the Base Balance Sheet.
(c) Except as otherwise specified in Schedule 2.11 hereto:
(i) all buildings, machinery and equipment of Seller and
each Subsidiary are in good repair, have been well maintained, substantially
conform with all applicable ordinances, regulations and zoning or other laws,
and do not encroach on property of others, and such machinery and equipment is
in good working order; and
(ii) as of the date hereof, there is no pending or
threatened change of any such ordinance, regulation or zoning or other law and
there is no pending or threatened condemnation of any such property.
2.12 Collectibility of Accounts Receivable. All of the accounts
receivable of Seller and its Subsidiaries shown or reflected on the Base Balance
Sheet, less a reserve for bad debts in the amount shown on the Base Balance
Sheet, are, and those existing at the time of Closing, less the reserve shown on
the Base Balance Sheet, will be, (a) valid and enforceable claims which arose
out of transactions with unaffiliated parties, (b) fully collectible within 90
days from invoice date through the Seller's normal means of collection, and (c)
subject to no set-off or counterclaim.
2.13 Inventories. Except as set forth in Schedule 2.13, all finished
goods, work in process and raw materials contained in the inventories of Seller
and its Subsidiaries reflected on the Base Balance Sheet are, and those existing
at the Closing will be, of a quality and quantity saleable in the ordinary
course of the business of Seller and its Subsidiaries at prevailing market
prices without discounts. Except as set forth in Schedule 2.13, all inventory
items shown on the Base Balance Sheet are, and those existing at the Closing
will be, priced at lower of cost (FIFO) or market, and reflect write-downs to
realizable values in the case of items which have become obsolete or unsaleable
(except at prices less than cost) through regular distribution channels in the
ordinary course of the business of Seller and its Subsidiaries. Subject to
write-downs complying with the preceding sentence, the values of the inventories
stated in the Base Balance Sheet reflect the normal inventory valuation policies
of Seller and its Subsidiaries and were determined in accordance with generally
accepted accounting principles, practices and methods, consistently applied.
Purchase commitments for raw materials and parts are not in excess of normal
requirements, and none are at prices materially in excess of current market
prices. Sales
commitments for finished goods are all at prices in excess of prices used in
valuing inventory, after allowing for selling expenses and a normal profit
margin. Since the date of the Base Balance Sheet, no inventory items have been
sold or disposed of except through sales in the ordinary course of business at
prices no less than prevailing market prices, and in no event less than cost.
2.14 Intellectual Property Rights.
(a) For purposes of this Section 2.14, "Intellectual Property"
means a patent, patent application, trademark or service mark, trademark or
service mark application, trade name or copyright, and "Computer Software" means
all information, however embodied, with respect to information processing
processes and programs, including software, firmware, databases and manuals and
documentation with respect thereto.
(b) All rights of ownership of, or material licenses to use,
Intellectual Property or Computer Software held by the Seller or any Subsidiary
are listed on Schedule 2.14. There are no Intellectual Property or Computer
Software rights, other than those set forth on such schedule, reasonably
necessary to the conduct of the business of Seller and its Subsidiaries as
presently conducted.
(c) Except as set forth on Schedule 2.14, all rights to
Intellectual Property required to be listed in Schedule 2.14 and in which Seller
or any Subsidiary claims ownership rights:
(i) have been duly registered in, filed in, or issued by
the United States Patent Office, United States Register of Copyrights, or the
corresponding offices of other countries identified on said schedule;
(ii) have been properly maintained and renewed in
accordance with all applicable laws and regulations in the United States and
such foreign countries;
(iii) in the case of copyrightable works of authorship,
were developed and authored as original works of authorship either by full time
employees of Seller or a Subsidiary within the normal scope of their duties as
works for hire, or by third persons as works for hire under an express written
obligation of assignment to Seller or a Subsidiary;
(iv) are owned exclusively by Seller or a Subsidiary, free
and clear of any attachments, liens, or encumbrances; no other person has any
right or interest in or license to use or right to license others to use any of
the Intellectual Property;
(v) are freely transferable (except as otherwise required
by law); and
(vi) are not subject to any outstanding order, decree,
judgment or stipulation.
(d) Except as set forth in Schedule 2.14, with respect to any
Computer Software used in or necessary to the business of the Seller and the
Subsidiaries and in which Seller or any Subsidiary claims ownership rights,
Seller and each Subsidiary have: (i) affixed in a timely manner appropriate
copyright notices complying with the Copyright Act of 1976, as amended,
and the rules and regulations of the United States Copyright Office to all
copies of such Computer Software, in object code form or any other form
distributed to the public; (ii) distributed such Computer Software only pursuant
to written agreements limiting the use, reproduction, distribution and
disclosure thereof, and requiring the licensees to preserve the confidentiality
thereof to an extent adequate to protect Seller's rights therein; and (iii)
disclosed or made available the source code or systems documentation thereof
only to employees or consultants of the Seller who required such disclosure or
access for the business purposes of the Seller.
(e) With respect to any Intellectual Property or Computer
Software set forth on Schedule 2.14 which Seller or any Subsidiary holds a
license to use, such license is adequate to the conduct of the business of
Seller and its Subsidiaries as presently conducted.
(f) No proceedings to which Seller or any Subsidiary is a party
have been commenced which (i) challenge the rights of Seller or any Subsidiary
in respect of the Intellectual Property or any Computer Software listed on
Schedule 2.14, or (ii) charge Seller or any Subsidiary with infringement of any
other person's rights in Intellectual Property or Computer Software; and no such
proceeding to which Seller or a Subsidiary is not a party has been filed, nor
are any such proceedings threatened to be filed.
(g) To Seller's knowledge, none of the rights in Intellectual
Property or Computer Software listed on Schedule 2.14 is being infringed by any
other person, and neither Seller nor any Subsidiary is infringing upon any
Intellectual Property or Computer Software rights of any other person.
(h) No director, officer or employee of Seller or any of its
Subsidiaries owns, directly or indirectly, in whole or in part, any Intellectual
Property right which Seller or any of its Subsidiaries has used, is presently
using, or the use of which is reasonably necessary to their respective
businesses as now conducted.
(i) In addition to the Intellectual Property described above,
Seller and each of its Subsidiaries have the right to use, free and clear of any
claims or rights of others except claims or rights described in Schedule 2.14,
all trade secrets, customer lists, manufacturing secret processes (collectively
"Trade Secrets") required for or used in the manufacture or marketing of all
products formerly or presently produced by Seller or such Subsidiary, including
products licensed from others. The Seller and its Subsidiaries have adopted
measures adequate to protect their Trade Secrets. Copies of all forms of
confidentiality or non-disclosure agreements utilized by Seller or any
Subsidiary to protect its Trade Secrets have been provided to Buyer. The Seller
and each of its Subsidiaries are not using or in any way making use of any Trade
Secrets of any third party, including without limitation a former employer of
any present or past employee of Seller or any Subsidiary.
(j) To Seller's knowledge, none of the Trade Secrets is being
infringed by any other person, and none of the Trade Secrets infringe upon the
trade secret rights of any other person.
2.15 Contracts and Commitments.
(a) Except for contracts, commitments, plans, agreements and
licenses
described in Schedule 2.15 hereto, neither Seller nor any Subsidiary is a party
to or subject to:
(i) any contract or agreement for the purchase of any
commodity, material, equipment or asset, except purchase orders in the ordinary
course for less than $1,000 each, such orders not exceeding in the aggregate
[$5,000];
(ii) any other contracts or agreements creating any
obligations of Seller or any Subsidiary after the date of the Base Balance
Sheet;
(iii) any contract or agreement providing for the purchase
of all or substantially all of its requirements of a particular product from a
supplier;
(iv) any contract or agreement which by its terms does not
terminate or is not terminable without penalty by Seller or such Subsidiary (or
its successor or assign) within one year after the date hereof;
(v) any contract or agreement for the sale or lease of its
products not made in the ordinary course of business;
(vi) any contract with any sales agent or distributor of
products of Seller or any Subsidiary;
(vii) any contract containing covenants limiting the
freedom of Seller or any Subsidiary to compete in any line of business or with
any person or entity; or
(viii) any license or franchise agreement (as licensor or
licensee or franchisor or franchisee).
(b) Except as described in Schedule 2.15, neither Seller nor
any Subsidiary is in default under any contracts, commitments, plans, agreements
or licenses to which they are party or by which they are bound or has knowledge
of any termination, cancellation, limitation or modification or change in any
business relationship with any material supplier or customer. For the purposes
hereof, a supplier or customer is material if it accounts for more than two
percent (2%) of the orders or sales, as the case may be, of Seller and its
Subsidiaries on a consolidated basis.
2.16 Labor and Employee Relations.
(a) Except as shown on Schedule 2.16 hereto, there are no
currently effective consulting or employment agreements or other material
agreements with individual consultants or employees to which Seller or any
Subsidiary is a party or by which they are bound. Complete and accurate copies
of all such written agreements have been delivered to Buyer. Also shown on
Schedule 2.16 are the name and rate of compensation (including all bonus
compensation) of each officer, employee or agent of Seller or any Subsidiary.
(b) Except as shown on Schedule 2.16, none of the employees of
Seller or any Subsidiary is covered by any collective bargaining agreement with
any trade or labor union, employees' association or similar association. Each of
Seller and the Subsidiaries has complied with applicable laws, rules and
regulations relating to the employment of labor, including
without limitation those relating to wages, hours, unfair labor practices,
discrimination, and payment of social security and similar taxes. There are no
representation elections, arbitration proceedings, labor strikes, slowdowns or
stoppages, material grievances or other labor troubles pending or overtly
threatened, with respect to the employees of Seller or any Subsidiary.
(c) There are no complaints against Seller or any Subsidiary
pending or overtly threatened before the National Labor Relations Board or any
similar state or local labor agencies, or before the Equal Employment
Opportunity Commission or any similar state or local agency, by or on behalf of
any employee of Seller or any Subsidiary.
(d) There is no contingent liability for sick leave, vacation
time, severance pay or similar items not set forth on the Base Balance Sheet or
on Schedule 2.16. The execution, delivery and performance of this Agreement and
the consummation of the transactions contemplated hereby will not trigger any
severance pay obligation under any contract or at law.
(e) The Seller has provided to Buyer a complete description of
all employment policies under which the Seller or any Subsidiary has operated or
which has been communicated to their employees.
2.17 Employee Benefits and ERISA.
(a) Schedule 2.17 (a) hereto describes all of the employee
compensation and benefit plans, agreements, commitments, practices or
arrangements of any type (including, but not limited to, plans described in
Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended
("ERISA")) offered, maintained or contributed to by Seller or any Subsidiary for
the benefit of current or former employees or directors of Seller or any
Subsidiary, or with respect to which Seller or any Subsidiary has or may have
any liability, whether direct or indirect, actual or contingent (including, but
not limited to, liabilities arising from affiliation under Section 414(b), (c),
(m) or (o) of the Code or Section 4001 of ERISA) (collectively, the "Benefit
Plans"). Neither Seller nor any Subsidiary has incurred any obligation for any
withdrawal liability or liability to make any other contributions with respect
to any employee benefit plan that is a "multiemployer plan" within the meaning
of Section 3(37) of ERISA. Neither Seller nor any Subsidiary has any liability,
whether direct or indirect, actual or contingent, with respect to any employee
pension plan as defined in Section 3(2) of ERISA, and which is intended to meet
the qualification requirements of the Code that is a defined benefit plan (as
defined in Section 3(35) of ERISA) and is subject to Title IV of ERISA, whether
or not terminated (including, but not limited to, liabilities arising from
affiliation under Section 414(b), (c), (m) or (o) of the Code or Section 4001 of
ERISA).
(b) With respect to each Benefit Plan described in Section
2.17(a) hereto, Seller has delivered to Buyer true and complete copies of: (i)
any and all plan documents (including, but not limited to, all amendments
thereto) and agreements (including, but not limited to, trust agreements,
insurance contracts, and custodial and investment management agreements); (ii)
any and all material employee communications (including, but not limited to, all
summary plan descriptions and material modifications thereto, claims, review
policies, distribution forms, and loan documents, as applicable); (iii) all
returns or reports required at any time within the last five (5) years by ERISA
or the Code (including, but not limited to, the five (5) most recent actuarial
reports, if applicable); (iv) the most recent annual and periodic accounting of
plan assets, if applicable; (v) the most recent determination letter received
from the Internal Revenue
Service (the "Service"), if applicable; and (vi) in the case of any unfunded or
self-insured plan or arrangement, a current estimate of accrued and anticipated
liabilities thereunder.
(c) With respect to each Benefit Plan described on Schedule
2.17(a) hereto and except as set forth on Schedule 2.17(c) hereto, (i) if
intended to qualify under Section 401(a) of the Code, such plan so qualifies,
and its trust is exempt from taxation under Section 501(a) of the Code; (ii)
such plan has been administered and enforced in accordance with its terms and
all applicable laws, regulations and rulings in all material respects; (iii) no
breach of fiduciary duty has occurred with respect to which Seller or any
Subsidiary or any Benefit Plan may be liable or otherwise damaged in any
material respect; (iv) no material disputes nor any audits or investigations by
any governmental authority are pending or threatened; (v) no "prohibited
transaction" (within the meaning of either Section 4975(c) of the Code or
Section 406 of ERISA) has occurred with respect to which Seller or any
Subsidiary or any Benefit Plan may be liable or otherwise damaged in any
material respect; (vi) all contributions (including, without limitation,
normally anticipated matching or discretionary contributions under defined
contribution plans), premiums, and other payment obligations have been accrued
on the consolidated financial statements of Seller (including without limitation
the Base Balance Sheet) in accordance with generally accepted accounting
principles, and, to the extent due, have been made on a timely basis, in all
material respects; (vii) all contributions or benefit payments made or required
to be made under such plan meet the requirements for deductibility under the
Code; (viii) Seller has expressly reserved the right to amend, modify or
terminate such plan, or any portion of it, at any time without liability to
itself; and (ix) no such plan requires Seller or any Subsidiary to continue to
employ any employee or director.
(d) With respect to each Benefit Plan described on Schedule
2.17(a) hereto and except as set forth on Schedule 2.17(d) hereto, (i) no such
plan is, or has ever been, subject to Title IV of ERISA; (ii) there is no excess
of actuarial accrued liabilities or "benefit liabilities" (as defined in Section
4001(a)(16) of ERISA), over the fair market value of Plan assets as of the
Closing Date; (iii) there has been no "accumulated funding deficiency," whether
or not waived, and no missed "quarterly contributions," (as these terms are
defined in ERISA); (iv) the funding methods used are acceptable under ERISA; (v)
the actuarial assumptions used are and have been reasonable, both individually
and collectively and calculated as if the participants receive lump sum payments
upon plan termination; (vi) there has been no "reportable event" (as defined in
Section 4043 of ERISA); (vii) there has been no termination or partial
termination; (viii) there has been no filing with the Pension Benefit Guaranty
Corporation ("PBGC") of an intent to terminate such plan, nor has the PBGC
instituted any proceedings to terminate such plan; (ix) no lien has been created
under Section 412(n) of the Code or Section 302(f) of ERISA; (x) neither Seller
nor any Subsidiary has received a notice of deficiency or liability or a demand
for payment from, incurred any liability to, been assessed a penalty by, or had
a lien perfected or enforced by the PBGC; and (xi) if such plan is a
multiemployer pension plan under which the Seller is obligated to make
contributions, there would be no withdrawal liability under Title IV of ERISA
upon the cessation of contributions to such plan as of the day of the Closing.
(e) With respect to each Benefit Plan described on Schedule
2.17(a) hereto which provides welfare benefits of the type described in Section
3(1) of ERISA: except as set forth on Schedule 2.17(e) hereto, (i) no such plan
provides medical or death benefits with respect to current or former employees
or directors of Seller or any Subsidiary, or their dependents, beyond their
termination of employment, other than coverage mandated by Sections 601-608 of
ERISA and 4980B of the Code; (ii) each such plan has been administered in
compliance with
Sections 601-609 of ERISA and 4980B of the Code; (iii) no such plan is or is
provided through a "multiple employer welfare arrangement" within the meaning of
Section 3(40) of ERISA; and (iv) no such plan has reserves, assets, surpluses or
prepaid premiums.
(f) The consummation of the transactions contemplated by this
Agreement will not (i) entitle any individual to severance pay pursuant to a
prior agreement with Seller; (ii) accelerate the time of payment or vesting
under any Benefit Plan; or (iii) increase the amount of compensation or benefits
due to any individual. No payment made or contemplated under any Benefit Plan
constitutes an "excess parachute payment" within the meaning of Section 280G of
the Code.
2.18 Environmental Matters.
(a) Except as disclosed in Schedule 2.18 hereto, any and all
waste oil, hazardous waste, hazardous substances, toxic substances or hazardous
materials used or generated by Seller or any Subsidiary have always been and are
being generated, used, stored or treated on or at any of the properties or
facilities owned or leased by Seller or any Subsidiary (for the purposes of this
Section, a "Site") in accordance with federal, state and local laws, regulations
and ordinances. Copies of any and all filings made or documents prepared under
the California Safe Drinking Water & Toxic Enforcement Act of 1986 and under
Title III of the Superfund Amendments and Reauthorization Act of 1986, including
without limitation material safety data sheets and chemical lists, have been
provided to Buyer.
(b) Except as disclosed in Schedule 2.18 hereto, no petroleum,
oil, hazardous waste, hazardous substances, toxic substances or hazardous
materials used or generated by Seller or any Subsidiary have ever been, are
being, are intended to be or are threatened with being spilled, released,
discharged, disposed, placed, leaked, or otherwise caused to become located in
the air, soil or water in, under or upon a Site. Seller has provided Buyer with
copies of all notices filed pursuant to the Comprehensive Environmental
Response, Compensation and Liability Act or comparable state law, including
without limitation any reports, whether oral or written, made to the National
Response Center, or other agencies.
(c) Except as disclosed in Schedule 2.18 hereto, no petroleum,
oil, hazardous substances or hazardous waste have ever been shipped by or for
Seller or any Subsidiary to other sites or facilities for treatment, storage or
disposal, and neither Seller nor any Subsidiary has received any notice that any
sites or facilities to which any such wastes have been shipped or sent are
subject to or threatened to become subject to any governmental response action
or clean up order. Seller has provided Buyer with copies of all manifests
documenting disposal of hazardous substances relating to operations of Seller
and its Subsidiaries.
(d) Except as disclosed in Schedule 2.18 hereto, all hazardous
materials and toxic substances have been shipped by Seller and its Subsidiaries
in accordance with all applicable federal, state and local laws, regulations and
ordinances, including The Hazardous Materials Transportation Act, the
regulations of the Department of Transportation, and any corresponding state and
local statute and regulations adopted pursuant to said acts.
(e) All underground tanks and other underground storage
facilities located at any Site are disclosed in Schedule 2.18 hereto and copies
of all notifications made to federal, state or local authorities pursuant to the
Resource Conservation and Recovery Act relating to
underground storage tanks have been provided to Buyer. As of the date hereof,
none of such underground tanks and other underground storage facilities are in
violation of any federal, state or local environmental law, regulation or
ordinance.
(f) Except as disclosed in Schedule 2.18 hereto, all wells,
water discharges and other water diversions on any Site are properly registered
and/or permitted under, and copies of such permits have been provided to Buyer,
and do not violate, any applicable federal, state or local law, regulation or
ordinance.
(g) Except as disclosed in Schedule 2.18 hereto, each of Seller
and its Subsidiaries has all necessary and applicable air permits and licenses,
and has properly registered (for air pollution control purposes) all air
emitting devices used in activities conducted by it, as required by applicable
federal, state or local law, regulation or ordinance. Copies of all such permits
have been provided to Buyer.
(h) Except as disclosed on Schedule 2.18 hereto, all asbestos
insulated equipment or areas on any Site are in compliance with all applicable
federal, state and local laws, current regulations, and ordinances.
(i) For purposes of this section, "hazardous waste", "hazardous
substances", "hazardous material", "oil", "petroleum", "toxic substances",
"manifest", "material safety data sheets", and "response action" shall have the
meaning set forth in the Resource Conservation and Recovery Act, The
Comprehensive Environmental Response, Compensation and Liability Act, The
Hazardous Materials Transportation Act, The Federal Water Pollution Control Act,
The Toxic Substances Control Act, and corresponding state and local statutes,
and ordinances and any amendments, or successor legislation to such Acts, or as
currently defined in any federal, state or local regulations adopted pursuant to
such Acts.
2.19 Permits. Each of Seller and its Subsidiaries holds all licenses,
permits and franchises which are required to permit it to conduct their
respective businesses as presently conducted, and all such licenses, permits and
franchises are listed on Schedule 2.19 hereto and are now, and will be after the
Closing, valid and in full force and effect, and Buyer shall have full benefit
of the same.
2.20 Warranty or Other Claims. Except as disclosed on Schedule 2.20,
there are no existing or threatened claim, nor are there any facts upon which a
claim could be based, against Seller or any Subsidiary for services or
merchandise which are defective or fail to meet any service or product
warranties. No claim has been asserted against Seller or any Subsidiary for
renegotiation or price redetermination of any business transaction, and there
are no facts upon which any such claim could be based.
2.21 Litigation. Except for matters described in Schedule 2.21 hereto,
there is no litigation pending or threatened against Seller or any Subsidiary
and there are no outstanding court orders, court decrees, or court stipulations
to which Seller or any of its Subsidiaries is a party or by which any of their
assets are bound, any of which (a) question this Agreement or affect the
transactions contemplated hereby, or (b) materially restrict the present
business, properties, operations, prospects, assets or condition, financial or
otherwise, of Seller or any Subsidiary, or (c) will result in any material
adverse change in the business, properties, operations, prospects, assets or the
condition, financial or otherwise, of Seller or any of its
Subsidiaries. Neither Seller nor any Subsidiary, has any reason to believe that
any further action, suit, proceeding or investigation which (a) questions this
Agreement or affects the transactions contemplated hereby, or (b) materially
restricts the present business, properties, operations, prospects, assets or
conditions, financial or otherwise, of Seller or any Subsidiary, or (c) will
result in any material adverse change in the business, properties, operations,
prospects, assets or condition, financial or otherwise, of Seller or any of its
Subsidiaries, which has not been identified in Schedule 2.21 may be brought
against the Seller or any of its Subsidiaries.
2.22 Borrowings and Guarantees. Except for the loan in the amount of
Five Hundred Thousand Dollars ($500,000) made pursuant to that certain Business
Loan and Security/Subordination Agreement by and among BBI, Seller and Concord
Growth Corporation (the "Loan Agreement") and as otherwise set forth on Schedule
2.22 hereto, there are no agreements and undertakings pursuant to which Seller
(a) is borrowing or is entitled to borrow any money, (b) is lending or has
committed itself to lend any money, or (c) is a guarantor or surety with respect
to the obligations of any person. Complete and accurate copies of all such
written agreements have been delivered to Buyer.
2.23 Financial Service Relations and Powers of Attorney. All of the
arrangements which Seller or any Subsidiary has with any bank depository
institution or other financial services entity, whether or not in Seller's or
the Subsidiary's name, are completely and accurately described on Schedule 2.23
hereto, indicating with respect to each of such arrangements the type of
arrangement maintained (such as checking account, borrowing arrangements, safe
deposit box, etc.) and the person or persons authorized in respect thereof.
Except as set forth in Schedule 2.23 or pursuant to the Loan Agreement, neither
the Seller nor any Subsidiary has any outstanding power of attorney.
2.24 Insurance. Schedule 2.24 contains a complete and correct list of
all policies of insurance maintained by Seller or any Subsidiary (including
insurance providing benefits for employees) in effect on the date hereof,
together with complete and correct information with respect to the premiums,
coverages, insurers, expiration dates, and deductibles in respect of such
policies. Except for amounts deductible under policies of insurance described on
such Schedule or with respect to risks assumed as a self-insurer and described
on such Schedule, neither Seller nor any Subsidiary is, or has been at any time,
subject to any liability as a self-insurer of the businesses or assets of Seller
or any Subsidiary that is reasonably likely to have a material adverse effect
upon the businesses, assets, revenues, condition (financial or otherwise) or
prospects of Seller or any Subsidiary. Except as set forth on Schedule 2.24,
there are no claims pending or overtly threatened, under any of said policies,
or disputes with insurers, and all premiums due and payable thereunder have been
paid, and all such policies are in full force and effect in accordance with
their respective terms.
2.25 Minute Books. The minute books of Seller and the minute books of
each Subsidiary accurately record all action taken by their respective
shareholders, boards of directors and committees thereof.
2.26 Finder's Fee. Except as set forth on Schedule 2.26 hereto, neither
the Seller, nor any Subsidiary nor, to Seller's knowledge any Principal
Stockholder, has incurred or become liable for any broker's commission or
finder's fee relating to or in connection with the transactions contemplated by
this Agreement.
2.27 Transactions with Interested Persons. No officer, supervisory
employee, director or stockholder of Seller or any Subsidiary, or their
respective spouses or children, (a) owns, directly or indirectly, on an
individual or joint basis, any material interest in, or serves as an officer or
director of, any customer, competitor or supplier of Seller or any Subsidiary,
or any organization which has a material contract or arrangement with Seller or
any Subsidiary, or (b) has any contract or agreement with the Seller or any
Subsidiary other than as disclosed on Schedule 2.27 hereto, and all such
agreements are, except as noted on such schedule, on arms-length terms.
2.28 Absence of Sensitive Payments. Neither Seller, any of its
Subsidiaries, nor any of their respective directors, officers, agents,
stockholders or employees, either on behalf of Seller or its Subsidiaries:
(a) has made or has agreed to make any contributions, payments
or gifts of funds or property to any governmental official, employee or agent
where either the payment or the purpose of such contribution, payment or gift
was or is illegal under the laws of the United States, any state thereof, or any
other jurisdiction (foreign or domestic);
(b) has established or maintained any unrecorded fund or asset
for any purpose, or has made any false or artificial entries on any of its books
or records for any reason; or
(c) has made or has agreed to make any contribution or
expenditure, or has reimbursed any political gift or contribution or expenditure
made by any other person, to candidates for public office, whether federal,
state or local (foreign or domestic) where such contributions were or would be a
violation of applicable law.
2.29 Disclosure of Material Information. Neither this Agreement nor any
schedule or exhibit hereto or certificate issued pursuant hereto contains any
untrue statement of a material fact, or omits to state a material fact necessary
to make the statements herein or therein not misleading, relating to the
business or affairs of Seller and its Subsidiaries. There is no fact which
materially adversely affects the business, condition (financial or otherwise) or
prospects of Seller and its Subsidiaries which has not been set forth herein or
in a Schedule hereto.
2.30 SEC Filings.
(a) Seller has filed or caused to be filed all registration
statements, reports or statements, and any amendments thereto, required to be
filed by it pursuant to Sections 13, 14 or 15(d) of the Securities Exchange Act
of 1934, and has heretofore furnished (or shall prior to the Closing Date
furnish) to Buyer copies, as applicable, of:
(i) Seller's Annual Report on Form 10-K for its three most
recent fiscal years;
(ii) Seller's Annual Report to Stockholders for its three
most recent fiscal years;
(iii) Seller's definitive Proxy Statements for all
meetings of stockholders since the beginning of its third preceding fiscal year;
and
(iv) Seller's Quarterly Report(s) on Form 10-Q for each
quarter since the end of its most recent fiscal year.
(b) The documents furnished to Buyer pursuant to paragraph (a)
were prepared in accordance with the requirements of the Securities Exchange Act
of 1934 and the rules and regulations thereunder in all material respects and do
not contain any misstatement of a material fact or omit to state a material fact
necessary in order to make the statements contained therein, in light of the
circumstances, not misleading.
ARTICLE 3. REPRESENTATIONS AND WARRANTIES OF BBI AND BUYER.
BBI and Buyer hereby represent and warrant to Seller as follows:
3.1 Organization of BBI and Buyer. Each of BBI and Buyer is a
corporation duly organized, validly existing and in good standing under the laws
of Massachusetts with full corporate power to own or lease its properties and to
conduct its business in the manner and in the places where such properties are
owned or leased or such business is conducted by each of them.
3.2 Authorization of Transaction. All necessary action, corporate or
otherwise, has been taken by BBI and Buyer to authorize the execution, delivery
and performance of this Agreement, and the same is the valid and binding
obligation of BBI and Buyer enforceable in accordance with its terms, subject to
laws of general application affecting creditor's rights generally.
3.3 No Conflict of Transaction With Obligations and Laws.
(a) Neither the execution, delivery or performance of this
Agreement, nor the performance of the transactions contemplated hereby, will:
(i) constitute a breach or violation of BBI or Buyer's Charter or by-laws; (ii)
conflict with or constitute (with or without the passage of time or the giving
of notice) a breach of, or default under any material agreement, instrument or
obligation to which BBI or Buyer is a party or by which either of them or their
respective assets are bound which would materially affect the performance by
Buyer of its obligations under this Agreement; or (iii) result in a violation of
any law, regulation, administrative order or judicial order applicable to BBI or
Buyer.
(b) The execution, delivery and performance of this Agreement
and the transactions contemplated hereby by Buyer do not require the consent,
waiver, approval, authorization, exemption of or giving of notice to any
governmental authority.
3.4 SEC Filings.
(a) Buyer has filed or caused to be filed all registration
statements, reports or statements, and any amendments thereto, required to be
filed by it pursuant to Sections 13, 14, or 15(d) of the Securities Exchange Act
of 1934, and has heretofore furnished (or shall prior to the Closing Date
furnish) to Seller copies, as applicable, of:
(i) Buyer's Annual Report on Form 10-K for its most recent
fiscal year;
(ii) Buyer's Annual Report to Stockholders for its most recent
fiscal year;
(iii) Buyer's definitive Proxy Statements for all meetings of
Stockholders since the beginning of its preceding fiscal year; and
(iv) Buyer's Quarterly Report(s) on Form 10-Q for each quarter
since the end of its most recent fiscal year.
3.5 Litigation. There is no litigation pending or, to the knowledge of
Buyer, threatened against Buyer which will have a material adverse effect on its
properties, assets or business or which would prevent or hinder the consummation
of the transactions contemplated by this Agreement.
3.6 Finder's Fee. Except as set forth on Schedule 3.6 hereto, Buyer has
not incurred or become liable for any broker's commission or finder's fee
relating to or in connection with the transactions contemplated by this
Agreement.
ARTICLE 4. COVENANTS OF SELLER.
Seller hereby covenants and agrees with Buyer as follows:
4.1 Conduct of Business. Between the date of this Agreement and the
Closing, Seller will do, and it will cause each of its Subsidiaries to do, the
following unless Buyer shall otherwise consent in writing:
(a) conduct its business only in the ordinary course and
refrain from changing or introducing any method of management or operations
except in the ordinary course of business and consistent with prior practices;
(b) refrain from making any purchase, sale or disposition of
any asset or property other than in the ordinary course of business, from
purchasing any capital asset costing more than $300 and from mortgaging,
pledging, subjecting to a lien or otherwise encumbering any of its properties or
assets;
(c) refrain from incurring any contingent liability as a
guarantor or otherwise with respect to the obligations of others, and from
incurring any other contingent or fixed obligations or liabilities except those
that are usual and normal in the ordinary course of business;
(d) refrain from making any change or incurring any obligation
to make a change in its Charter or by-laws or authorized or issued capital
stock, except as contemplated by this Agreement;
(e) refrain from declaring, setting aside or paying any
dividend or making any other distribution in respect of capital stock, or making
any direct or indirect redemption, purchase or other acquisition of capital
stock, of Seller or any Subsidiary other than a wholly-owned Subsidiary;
(f) refrain from entering into any employment contract or
making any change in the compensation payable or to become payable to any of its
officers, employees or agents;
(g) refrain from prepaying any loans from its stockholders,
officers or directors (if any) or making any change in its borrowing
arrangements;
(h) use its best efforts to prevent any change with respect to
its banking arrangements;
(i) use its best efforts to keep intact its business
organization, to keep available its present officers, agents and employees and
to preserve the goodwill of all suppliers, customers and others having business
relations with it;
(j) have in effect and maintain at all times all insurance of
the kind, in the amount and with the insurers set forth in Schedule 2.24 hereto
or equivalent insurance with any substitute insurers approved by Buyer; and
(k) permit Buyer and its authorized representatives to have
full access to all its properties, assets, records, tax returns, contracts and
documents and furnish to Buyer or its authorized representatives such financial
and other information with respect to its business or properties as Buyer may
from time to time reasonably request.
(l) promptly advise Buyer of additions, deletions or other
changes required to be made to the Schedules hereto to make such Schedules
accurate and complete as of the Closing solely as a result of the operation of
the business of Seller in a manner consistent with the covenants of this
Agreement, and to furnish Buyer with such revised Schedules at or prior to the
Closing.
4.2 Authorization from Others. Prior to the Closing, Seller will have
obtained, and will cause its Subsidiaries to have obtained, all authorizations,
consents and permits of others required to permit the consummation by Seller and
its Subsidiaries of the transactions contemplated by this Agreement.
4.3 Breach of Representations and Warranties. Promptly upon the
occurrence of, or promptly upon Seller's becoming aware of the impending or
threatened occurrence of, any event which would cause or constitute a breach, or
would have caused or constituted a breach had such event occurred or been known
to Seller prior to the date hereof, of any of the representations and warranties
of Seller contained in or referred to in this Agreement, Seller shall give
detailed written notice thereof to Buyer and shall use its best efforts to
prevent or promptly remedy the same.
4.4 Consummation of Agreement. The Seller shall use its best efforts to
perform and fulfill all conditions and obligations on its part to be performed
and fulfilled under this Agreement, to the end that the transactions
contemplated by this Agreement shall be fully carried out. To this end, Seller
will obtain all necessary authorizations or approvals of its stockholders and
Board of Directors, to the sale of assets contemplated by this Agreement and the
dissolution of Seller in accordance with the laws of the state of incorporation
of Seller, which shall include as integral parts thereof:
(a) the transfer to Buyer of the Subject Assets upon the terms
and conditions set forth in this Agreement;
(b) cessation of all business by Seller as Source Scientific,
Inc. from and after the Closing, except in connection with its liquidation; and
(c) authorization to the officers and directors of Seller to
discharge all debts and obligations of Seller (other than those assumed by Buyer
hereunder), and to distribute in liquidation the purchase price received by
Seller as provided herein.
4.5 Compliance with Securities Laws. As soon as practicable after
execution of this Agreement, Seller shall cause its counsel to initiate
preparation of preliminary proxy materials in accordance with the Securities
Exchange Act of 1934, and the rules and regulations thereunder, for a special
meeting of the Company's stockholders at which the stockholders will be asked to
approve the transactions contemplated hereby. Such proxy materials shall be in
form and substance satisfactory to the Buyer and its counsel.
ARTICLE 5. COVENANTS OF BBI AND BUYER.
BBI and Buyer hereby covenant and agree with Seller as follows:
5.1 Authorization from Others. Prior to the Closing Buyer will have
obtained all authorizations, consents and permits of others required to permit
the consummation by BBI and Buyer of the transactions contemplated by this
Agreement.
5.2 Consummation of Agreement. The Buyer shall use its best efforts to
perform and fulfill all conditions and obligations on its part to be performed
or fulfilled under this Agreement, to the end that the transactions contemplated
by this Agreement shall be fully carried out. To this end, BBI will obtain any
approvals of its stockholders or Board of Directors and Buyer will obtain any
approvals of its stockholders or Board of Directors which may be required in
order to consummate the transactions contemplated hereby.
5.3 Disclosure of Adverse Change. Prior to the Closing, Buyer shall
advise Seller of any fact which materially adversely affects the business,
condition (financial or otherwise) or prospects of Buyer and BBI not otherwise
previously publicly disclosed. To this end, Buyer shall have the right, prior to
disclosing such fact to Seller, to require Seller to enter into a
confidentiality agreement relating to non-disclosure of such fact consistent
with compliance under the Securities Exchange Act of 1934.
ARTICLE 6. CONDITIONS TO OBLIGATIONS OF BBI AND BUYER.
The obligations of BBI and Buyer to consummate this Agreement and the
transactions contemplated hereby are subject to the condition that on or before
the Closing Date the actions required by this Article 6 will have been
accomplished.
6.1 Shareholder Authorization. This Agreement and the transactions
contemplated hereby shall have been duly approved by the affirmative vote of
Seller's stockholders, as required by the laws of the state of incorporation of
Seller.
6.2 Dissenting Stockholders. Holders of not more than one-half percent
(.5%) of the shares of the Common Stock of Seller shall have taken steps to
preserve the rights of dissenting stockholders afforded by the laws of the state
of incorporation of Seller, and Seller shall have delivered to Buyer a true and
correct list of the names, addresses and numbers of shares held by each holder
of dissenting shares of Seller and the steps taken by each such holder as
required by the laws of Seller's jurisdiction of incorporation governing
appraisal rights.
6.3 Representations; Warranties; Covenants. Each of the representations
and warranties of Seller contained in Article 2 shall be true and correct as
though made on and as of
the Closing Date. Seller shall, on or before the Closing Date, have performed
all of its obligations hereunder which by the terms hereof are to be performed
on or before the Closing Date. Seller shall have delivered to Buyer a
certificate of Seller's President and Chief Financial Officer dated as of the
Closing Date, in form and substance satisfactory to BBI and Buyer, to the effect
that the statements contained in Sections 6.3 and 6.4 are true and that all
other conditions to BBI's and Buyer's obligations hereunder have been satisfied.
Seller shall have delivered to Buyer a certificate of Seller's President and
Chief Financial Officer, dated as of the Closing Date, in form and substance
satisfactory to BBI and Buyer, confirming that the conditions set forth in
Sections 6.1 and 6.2 have been fulfilled.
6.4 No Material Adverse Change. There shall have been no material
adverse change in the financial condition, prospects, properties, assets,
liabilities, business or operations of Seller since the date hereof, whether or
not in the ordinary course of business.
6.5 Opinion of Seller's Counsel.
(a) At the Closing, BBI and Buyer shall have received from
Susan L. Preston, Esquire, counsel for Seller, an opinion dated as of the
Closing, in form and substance satisfactory to BBI and Buyer.
(b) At the Closing, BBI and Buyer shall have received from
Messrs. Arter & Hadden, counsel for Seller, an opinion dated as of the Closing,
in form and substance satisfactory to BBI and Buyer.
6.6 Employment Contracts. Each of the individuals listed on Schedule
6.6 hereto shall have accepted employment with Buyer and executed and delivered
to Buyer an employment agreement having substantially the terms and conditions
contained in Exhibit 6.6 attached hereto, and all employment contracts to which
Seller is a party shall have been terminated.
6.7 Non-Competition Contracts. Seller and each of the individuals
listed on Schedule 6.7 hereto shall have executed and delivered to Buyer
non-competition agreements having substantially the terms and conditions of
Exhibit 6.7 attached hereto.
6.8 Approval of Board of Directors. The transactions contemplated by
this Agreement shall have been reviewed and approved by the Board of Directors
of Buyer and BBI and their respective stockholders to the extent necessary.
6.9 Approval of Buyer's Counsel. All actions, proceedings, instruments
and documents required to carry out this Agreement and all related legal matters
contemplated by this Agreement shall have been approved by counsel for Buyer,
provided that the approval of such counsel shall not be unreasonably withheld.
6.10 Absence of Certain Litigation. There shall not be any (a)
injunction, restraining order or order of any nature issued by any court of
competent jurisdiction which directs that this Agreement or any material
transaction contemplated hereby shall not be consummated as herein provided, (b)
suit, action or other proceeding by any federal, state, local or foreign
government (or any agency thereof) pending before any court or governmental
agency, or threatened to be filed or initiated, wherein such complainant seeks
the restraint or prohibition of the
consummation of any material transaction contemplated by this Agreement or
asserts the illegality thereof, or (c) suit, action or other proceeding by a
private party pending before any court or governmental agency, or threatened to
be filed or initiated, which in the opinion of counsel for Buyer is likely to
result in the restraint or prohibition of the consummation of any material
transaction contemplated hereby or the obtaining of an amount in payment (or
indemnification) of material damages from or other material relief against any
of the parties or against any directors or officers of BBI or Buyer, in
connection with the consummation of any material transaction contemplated
hereby.
6.11 FIRPTA Certificate. At the Closing, the Seller will deliver to
Buyer certificates which satisfy the requirements of the regulations under
Section 1445 of the Internal Revenue Code of 1986, as amended.
6.12 Consents and Waivers. Seller shall have obtained any necessary
consents or waivers to assure Buyer of the benefits of all leases, contracts,
commitments and rights, to the extent that the assignment of any lease,
contract, commitment or right requires the consent of parties other than Seller.
6.13 Escrow Agreement. There shall have been executed and delivered to
BBI and Buyer an Escrow Agreement in substantially the form attached hereto as
Exhibit 1.3, pursuant to which $250,000 of the purchase price shall be deposited
in escrow at the Closing to secure payment of any purchase price adjustment or
indemnification payable to BBI and Buyer hereunder by reason of the breach of
any of the representations and warranties of Seller or failure of Seller to
perform any of its obligations hereunder, and said amounts shall have been
deposited with the Escrow Agent pursuant to said Escrow Agreement.
6.14 Convertible Debentures. Holders of the convertible debentures of
Seller in the principal amount of $629,000 shall have converted the principal
amount of such debentures and all accrued interest thereon ($70,898 as of
January 31, 1997) into 13,997,960 shares of Seller's Common Stock and terminated
in writing their stock purchase warrants, in full satisfaction of Seller's
obligations to such debenture holders.
6.15 Opinion of Independent Accountants. Buyer shall have received in
form and substance reasonably satisfactory to it, reports and opinions on such
business, financial and legal matters in connection with the transactions
contemplated by this Agreement as it deems pertinent, including, without
limitation, a satisfactory report from Buyer's independent accountants, Coopers
& Lybrand, regarding Seller's business and financial condition.
6.16 Opinion of Investment Banking Firm. Buyer shall have received in
form and substance reasonably satisfactory to it, an opinion from a recognized
investment banking firm to the effect that the purchase price is fair to Buyer's
stockholders from a financial point of view.
6.17 Due Diligence. The results of Buyer's due diligence investigation
of Seller shall be satisfactory to Buyer, in Buyer's sole discretion. Any
additions, deletions or other changes to be made to the Schedules hereto
pursuant to Section 4.1(1) shall be satisfactory to Buyer, in Buyer's sole
discretion.
6.18 Facility Lease. The lease with respect to Seller's Garden Grove
facility located at 7390 Lincoln Way, Garden Grove, California (the "Garden
Grove Lease") shall have been
amended, in form and substance satisfactory to Buyer, to reduce to approximately
25,000 square feet (one floor) the space leased by Seller, and to reduce the
payment due under the Garden Grove Lease in proportion to the decrease in the
amount of space leased.
6.19 Reduction of Interest Payments. Concord Growth Corporation
("Concord") shall have agreed in writing to a reduction in the minimum interest
payment to $2,500 per month in return for an increase in interest to the prime
rate plus five percent (5%) and a reduction in advancement to seventy percent
(70%), along with payment of the line of credit loan by April 30, 1997, and
Concord shall have further agreed in writing that upon repayment of the
principal amount of Seller's line of credit loan with Concord and all accrued
but unpaid interest thereon, Concord shall waive its right to prepayment
penalties of any kind.
6.20 Consents to Transactions. BBI's lending bank, The First National
Bank of Boston, shall have consented to the transactions contemplated hereby.
6.21 Authorization. Seller shall have obtained and will cause its
Subsidiaries to have obtained all authorities, consents and permits of others
required to permit the consummation by Seller and its Subsidiaries of the
transactions contemplated by this Agreement.
6.22 Bulk Sales Law. Seller shall have complied with the obligations
imposed on vendors under the Bulk Sales Act, or the equivalent, as a result of
the transactions contemplated by this Agreement.
ARTICLE 7. CONDITIONS TO OBLIGATIONS OF SELLER
.
The obligations of Seller to consummate this Agreement and the transactions
contemplated hereby are subject to the condition that on or before the Closing
the actions required by this Article 7 will have been accomplished.
7.1 Shareholder Authorization. This Agreement and the transactions
contemplated hereby shall have been duly approved by the affirmative vote of the
stockholders of Seller as required by Seller's state of incorporation.
7.2 Representations; Warranties; Covenants. Each of the representations
and warranties of Buyer contained in Article 3 shall be true and correct as
though made on and as of the Closing; Buyer shall, on or before the Closing,
have performed all of its obligations hereunder which by the terms hereof are to
be performed on or before the Closing; and Buyer shall have delivered to Seller
a certificate of the President and any Vice President of Buyer dated as of the
Closing to such effect.
ARTICLE 8. TERMINATION OF AGREEMENT.
8.1 Termination. At any time prior to the Closing, this Agreement may
be terminated (a) by mutual consent of the parties with the approval of their
respective Board of Directors, notwithstanding prior approval of this Agreement
by the stockholders of any party, (b) by either party if there has been a
material misrepresentation, breach of warranty or breach of covenant by the
other party in its representations, warranties and covenants set forth herein,
(c) by Buyer if the conditions stated in Article 6 have not been satisfied at or
prior to the Closing, or (d) by
Seller if the conditions stated in Article 7 have not been satisfied at or prior
to the Closing.
8.2 Right to Proceed. Anything in this Agreement to the contrary
notwithstanding, if any of the conditions specified in Article 6 hereof have not
been satisfied, Buyer shall have the right (but not the obligation) to proceed
with the transactions contemplated hereby without waiving its rights hereunder,
and if any of the conditions specified in Article 7 hereof have not been
satisfied, Seller shall have the right (but not the obligation) to proceed with
the transactions contemplated hereby without waiving its rights hereunder.
ARTICLE 9. RIGHTS AND OBLIGATIONS SUBSEQUENT TO CLOSING.
9.1 Survival of Warranties. All representations, warranties,
agreements, covenants and obligations herein or in any schedule, certificate or
financial statement delivered by either party to the other party incident to the
transactions contemplated hereby are material, shall be deemed to have been
relied upon by the other party and shall survive through and until March 31,
1998, regardless of any investigation and shall not merge in the performance of
any obligation by either party hereto.
9.2 Collection of Assets. Subsequent to the Closing, Buyer shall have
the right and authority to collect all receivables and other items transferred
and assigned to it by Seller hereunder and to endorse with the name of Seller
any checks received on account of such receivables or other items, and Seller
agrees that it will promptly transfer or deliver to Buyer from time to time
after Closing, any cash or other property that Seller may receive with respect
to any claims, contracts, licenses, leases, commitments, sales orders, purchase
orders, receivables of any character or any other items required to be
transferred by it to Buyer pursuant to the provisions hereof.
9.3 Payment of Debts. Seller shall as promptly as possible after the
Closing pay all debts and obligations not to be assumed by Buyer hereunder.
ARTICLE 10. INDEMNIFICATION.
10.1 Definitions. For purposes of this Article 10:
"Losses" means all losses, damages (including, without limitation,
punitive and consequential damages), liabilities, payments and obligations, and
all expenses related thereto. Losses shall include any reasonable legal fees and
costs incurred by any of the Indemnified Persons subsequent to the Closing in
defense of or in connection with any alleged or asserted liability, payment or
obligation, whether or not any liability or payment, obligation or judgment is
ultimately imposed against the Indemnified Persons and whether or not the
Indemnified Persons are made or become parties to any such action.
"Buyer's Indemnified Persons" means BBI and the Buyer, and their
respective directors, officers, employees, stockholders and agents.
"Indemnified Person" means any person entitled to be indemnified
under this Article 10.
"Indemnifying Person" means any person obligated to indemnify
another person
under this Article 10.
"Seller's Indemnified Persons" means the Seller.
"Third Party Action" means any written assertion of a claim, or
the commencement of any action, suit, or proceeding, by a third party as to
which any person believes it may be an Indemnified Person hereunder.
10.2 Indemnification by Seller.
(a) Subject to the limitations in paragraph (b) below, Seller
agrees to defend, indemnify and hold harmless Buyer's Indemnified Persons from
and against all Losses directly or indirectly incurred by or sought to be
imposed upon any of them:
(i) resulting from, relating to or arising out of any
breach of any of the representations or warranties made by Seller in or pursuant
to this Agreement or any schedule hereto or in any agreement, document or
instrument executed and delivered pursuant hereto or in connection with the
Closing;
(ii) resulting from or arising out of any breach of any
covenant or agreement made by Seller in or pursuant to this Agreement;
(iii) in respect of any liability or obligation of Seller
or any Subsidiary not included in the Assumed Liabilities;
(iv) resulting from or arising out of any liability,
payment or obligation arising out of any litigation or similar matter required
to be described on Schedule 2.21, except to the extent of reserves with respect
thereto on the Base Balance Sheet;
(v) resulting from or arising out of any liability,
payment or obligation in respect of any taxes for all periods, or portions
thereof, ending on or before the Closing Date, owing by Seller or any Subsidiary
of any kind or description (including interest and penalties with respect
thereto);
(vi) resulting from or arising out of any governmental or
third party claims for damages or clean-up costs under any environmental law
arising out of the operations of the Seller or any Subsidiary on or before the
Closing Date, except to the extent of reserves with respect thereto on the Base
Balance Sheet.
(b) The right to indemnification under paragraph 10.2(a) is
subject to the following limitations: Seller shall have no liability under
paragraph 10.2(a) unless one or more of the Buyer's Indemnified Persons gives
written notice to Seller asserting a claim for Losses, including reasonably
detailed facts and circumstances pertaining thereto, before the earlier of the
running of any applicable statute of limitations or March 31, 1998.
10.3 Indemnification by Buyer.
(a) From and after the Closing Date, Buyer shall indemnify and
hold harmless Seller's Indemnified Persons from any and all Losses directly or
indirectly incurred by or sought to be imposed upon them:
(i) resulting from or arising out of any breach of any of
the representations or warranties made by Buyer, in or pursuant to this
Agreement or in any agreement, document or instrument executed and delivered
pursuant hereto or in connection with the Closing; and
(ii) resulting from or arising out of any breach of any
covenant or agreement made by Buyer in or pursuant to this Agreement.
10.4 Defense of Third Party Actions.
(a) Promptly after receipt of notice of any Third Party Action,
any person who believes he, she or it may be an Indemnified Person will give
notice to the potential Indemnifying Person of such action. The omission to give
such notice to the Indemnifying Person will not relieve the Indemnifying Person
of any liability hereunder, except to the extent, but only to the extent, it was
prejudiced thereby, nor will it relieve it of any liability which it may have
other than under this Article 10.
(b) Upon receipt of a notice of a Third Party Action, the
Indemnifying Person shall have the right, at its option and at its own expense,
to participate in and be present at the defense of such Third Party Action, but
not to control the defense, negotiation or settlement thereof, which control
shall remain with the Indemnified Person, unless the Indemnifying Person makes
the election provided in paragraph (c) below.
(c) By written notice within 45 days after receipt of a notice
of a Third Party Action, an Indemnifying Person may elect to assume control of
the defense, negotiation and settlement thereof, with counsel reasonably
satisfactory to the Indemnified Person; provided, however, that the Indemnifying
Person agrees (i) to promptly indemnify the Indemnified Person for its expenses
to date, and (ii) to hold the Indemnified Person harmless from and against any
and all Losses caused by or arising out of any settlement of the Third Party
Action approved by the Indemnifying Person or any judgment in connection with
that Third Party Action. The Indemnifying Persons shall not in the defense of
the Third Party Action enter into any settlement which does not include as a
term thereof the giving by the third party claimant of an unconditional release
of the Indemnified Person, or consent to entry of any judgment except with the
consent of the Indemnified Person.
(d) Upon assumption of control of the defense of a Third Party
Action under paragraph (c) above, the Indemnifying Person will not be liable to
the Indemnified Person hereunder for any legal or other expenses subsequently
incurred in connection with the defense of the Third Party Action, other than
reasonable expenses of investigation.
(e) If the Indemnifying Person does not elect to control the
defense of a Third Party Action under paragraph (c), the Indemnifying Person
shall promptly reimburse the Indemnified Person for expenses incurred by the
Indemnified Person in connection with defense of such Third Party Action, as and
when the same shall be incurred by the Indemnified Person.
(f) Any person who has not assumed control of the defense of
any Third Party Action shall have the duty to cooperate with the party which
assumed such defense.
10.5 Miscellaneous. Buyer's Indemnified Persons shall be entitled to
indemnification under Section 10.2(a) and Seller's Indemnified Persons shall be
entitled to indemnification under Section 10.3(a), regardless of whether the
matter giving rise to the applicable liability, payment, obligation or expense
may have been previously disclosed to any such person and limited only in
accordance with Section 10.4(a) notice requirements.
10.6 Payment of Indemnification. Claims for indemnification under this
Article 10 other than pursuant to Section 10.3 shall be paid pursuant to the
terms of the Escrow Agreement with respect to amounts held thereunder and
otherwise by the Seller, and any claims for indemnification under this Article
10 shall be paid or otherwise satisfied by Indemnifying Persons within 30 days
after notice thereof is given by the Indemnified Person if the Indemnifying
Person does not dispute the claim, or within five (5) days of resolution of any
disputed claim.
ARTICLE 11. MISCELLANEOUS.
11.1 Fees and Expenses. Except as set forth below, each of the parties
will bear its own expenses in connection with the negotiation and the
consummation of the transactions contemplated by this Agreement, and no expenses
of Seller relating in any way to the purchase and sale of the Subject Assets
hereunder shall be charged to or paid by Buyer or included in any account of
Seller as of the Closing.
Seller shall pay to Buyer upon demand a fee equal to all Expenses (as
defined below) (the "Termination Fee"), payable by certified check or by federal
funds wire transfer, if (i) the requisite approval of the transactions
contemplated hereby by Seller's stockholders is not obtained at Seller's Special
Meeting of Stockholders, (ii) the Special Meeting of Stockholders does not occur
prior to April 30, 1997 or if it does occur, Seller's stockholders do not
approve the transactions by the requisite vote, (iii) the conditions specified
in Articles 6 and 7 hereof are not satisfied (other than regulatory approvals
and breach by Buyer), (iv) Seller materially breaches the letter agreement dated
February 4, 1997 between Buyer and Seller (the "Letter Agreement"), or (v) this
Agreement is terminated by Seller for any reason other than as a result of a
willful and material breach of this Agreement by Buyer; provided, however, that
the Termination Fee shall be Buyer's Expenses plus $250,000 if Seller (or any
affiliate) enters into an acquisition with a person other than Buyer, within one
year of the date of the Letter Agreement.
For purposes of this Article 8, "Expenses" means all fees and expenses
incurred or paid by or on behalf of Buyer or any of its affiliates in connection
with the consummation of any of the transactions contemplated hereby, by the
Letter Agreement, by the Business Loan and Security/Subordination Agreement, or
the transactions contemplated hereby or thereby, including all fees and expenses
of counsel, investment banking firms, accountants, experts and consultants to
Buyer or any of its affiliates and a reasonable allocation of corporate
overhead. In the event that this Agreement is so terminated, each party will
return all papers, documents, financial statements and other data furnished to
it by or with respect to each other party to such other party (including any
copies thereof made by the first party).
11.2 Notices. Any notice or other communication in connection with this
Agreement shall be deemed to be delivered if in writing (or in the form of a
telegram or facsimile transmission) addressed as provided below and if either
(a) actually delivered electronically or physically at said address, or (b) in
the case of a letter, three business days shall have elapsed
after the same shall have been deposited in the United States mail, postage
prepaid and registered or certified, return receipt requested:
If to the Seller, to:
Source Scientific, Inc.
7390 Lincoln Way
Garden Grove, CA 92841
Attention: Richard A. Sullivan, President
with a copy to:
Weiss, Jensen, Ellis & Howard
520 Pike Street, Suite 2600
Seattle, WA 98101
Attention: Susan L. Preston
If to BBI or Buyer, to:
Boston Biomedica, Inc.
375 West Street
West Bridgewater, MA 02379
Attention: Richard T. Schumacher, President
with a copy to:
Brown, Rudnick, Freed & Gesmer
One Financial Center
Boston, MA 02111
Attention: Steven R. London, Esquire and John G. Nossiff, Jr., Esquire
and in any case at such other address as the addressee shall have specified by
written notice. All periods of notice shall be measured from the date of
delivery thereof.
11.4 Publicity and Disclosures. No press releases or any public
disclosure, either written or oral, of the transactions contemplated by this
Agreement shall be made without the prior knowledge and written consent of BBI
and Seller. Seller and BBI acknowledge, however, that, as public companies,
Seller and BBI may be legally obligated to make certain public announcements
from time to time regarding their respective businesses, including one or more
announcements regarding the transactions contemplated by this Agreement.
Accordingly, BBI and Seller agree that, notwithstanding any other provision of
this Section 11.4, BBI and Seller shall be free to make such public
announcements regarding the transactions contemplated by this Agreement at such
time as Buyer, or BBI or Seller reasonably believes such announcements are
required in order to comply with applicable federal and state securities laws,
provided that each provides the other with a copy of such announcement at least
24 hours prior to its release.
11.5 Non-Solicitation. Seller shall not, and shall use its best efforts
to cause its affiliates, as that term is interpreted under the Securities Act of
1933, as amended, and each of its officers, directors, employees,
representatives, and agents not to, directly or indirectly (a)
encourage, solicit, initiate, engage or participate in discussions or
negotiations with any person or entity (other than Buyer) concerning any merger,
consolidation, sale of material assets, tender offer, recapitalization,
accumulation of any equity interest in Seller, proxy solicitation or other
business combination involving Seller or any Subsidiary or (b) provide any
nonpublic information concerning the business, properties or assets of Seller or
any subsidiary to any person or entity (other than Buyer) other than in
connection with the sale of products in the ordinary course of business.
11.6 Confidentiality. The parties agree that they will keep
confidential and not disclose or divulge any confidential, proprietary or secret
information which they may obtain from the other in connection with the
transactions contemplated herein, or pursuant to inspection rights granted
hereunder unless such information is or hereafter becomes public information.
11.7 Entire Agreement. This Agreement (including all exhibits or
schedules appended to this Agreement and all documents delivered pursuant to or
referred to in this Agreement, all of which are hereby incorporated herein by
reference) constitutes the entire agreement between the parties, and all
promises, representations, understandings, warranties and agreements with
reference to the subject matter hereof and inducements to the making of this
Agreement relied upon by any party hereto, have been expressed herein or in the
documents incorporated herein by reference.
11.8 Severability. The invalidity or unenforceability of any provision
of this Agreement shall not affect the validity or enforceability of any other
provision hereof.
11.9 Assignability. This Agreement may not be assigned otherwise than
by operation of law (a) by BBI or Buyer without the prior written consent of
Seller, or (b) by Seller without the prior written consent of Buyer. However,
any or all rights of BBI and Buyer to receive performance (but not the
obligations of Buyer to Seller hereunder) and rights to assert claims against
Seller hereunder, may be assigned by Buyer to (i) any direct or indirect
subsidiary, parent or other affiliate of Buyer, or (ii) any person or entity
extending credit to BBI or Buyer to finance the purchase price. This Agreement
shall inure to the benefit of and be binding upon the parties hereto and their
respective successors and permitted assigns.
11.10 Amendment. This Agreement may be amended only by a written
agreement executed by BBI, Buyer and Seller.
11.11 Attorney-in-Fact. The Seller hereby irrevocably appoints and
designates Richard T. Schumacher or his successor unanimously appointed in
written notice by the Seller to the Buyer (the "Agent") as its agent and
attorney-in-fact to accept service of process immediately following the Closing.
11.12 Governing Law; Venue.
(a) This Agreement shall be governed by and construed in
accordance with the laws of the Commonwealth of Massachusetts (other than the
choice of law principles thereof), except that any representations and
warranties with respect to real and tangible property shall be governed by and
construed in accordance with the laws of the jurisdiction where such property is
situated if other than in the Commonwealth of Massachusetts.
(b) Any claim, action, suit or other proceeding initiated by
any of the Sellers' Indemnified Persons against Buyer, or by any of the Buyer's
Indemnified Persons against any Seller, under or in connection with this
Agreement may be asserted, brought, prosecuted and maintained in any Federal or
state court in the Commonwealth of Massachusetts, as the party bringing such
action, suit or proceeding shall elect, having jurisdiction over the subject
matter thereof, and Seller and Buyer hereby waive any and all rights to object
to the laying of venue in any such court, the assertion of personal jurisdiction
over such persons by any such court and to any right to claim that any such
court may be an inconvenient forum. Seller and Buyer hereby submit themselves to
the jurisdiction of each such court and agree that service of process on them in
any such action, suit or proceeding may be effected by the means by which
notices are to be given to it under this Agreement.
11.13 Counterparts. This Agreement may be executed in multiple
counterparts, each of which shall be deemed in original but all of which
together shall constitute one and the same instrument.
11.14 Effect of Table of Contents and Headings. Any table of contents,
title of an article or section heading herein contained is for convenience of
reference only and shall not affect the meaning of construction of any of the
provisions hereof.
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed in multiple counterparts as of the date set forth above by their duly
authorized representatives.
BOSTON BIOMEDICA, INC.
BY: /s/ Richard T. Schumacher
--------------------------------
Richard T. Schumacher, President
BBI-SOURCE SCIENTIFIC, INC.
BY: /s/ Richard T. Schumacher
--------------------------------
Name: Richard T. Schumacher
Title: President
SOURCE SCIENTIFIC, INC.
BY: /s/ Richard A. Sullivan
--------------------------------
Richard A. Sullivan, President
ASSETS FOR CASH PURCHASE AGREEMENT
List of Schedules and Exhibits
Schedule 1.1 Assets
Schedule 1.2(a) - Liabilities Assumed
Schedule 2.1 - Qualification of Seller
Schedule 2.2 - Options, Warrants and Convertible
Securities
Schedule 2.3 - Subsidiaries
Schedule 2.7 - Financial Statements of the Seller
Schedule 2.8 - Undisclosed Liabilities
Schedule 2.9 - Changes Since Base Balance Sheet Date
Schedule 2.10 Payment and Taxes
Schedule 2.11 - Property, Leases and Equipment
Schedule 2.13 Inventories
Schedule 2.14 - Intellectual Property Rights
Schedule 2.15 - Contracts and Commitments
Schedule 2.16 - Labor and Employee Relations
Schedule 2.17(a) - ERISA; Compensation and Benefit Plans
Schedule 2.17(c) ERISA; Compensation and Benefit Plans
Schedule 2.17(d) ERISA; Compensation and Benefit Plans
Schedule 2.17(e) ERISA; Compensation and Benefit Plans
Schedule 2.18 - Environmental Matters
Schedule 2.19 - Permits
Schedule 2.20 Claims
Schedule 2.21 - Litigation
Schedule 2.22 - Borrowings and Guarantees
Schedule 2.23 - Banking and Financial Arrangements
Schedule 2.24 - Insurance
Schedule 2.26 Finder's Fees
Schedule 2.27 Transactions with Interested Persons
Schedule 6.6 - Parties to Employment Contracts
Schedule 6 7 Parties to Non-Competition Contracts
Exhibit 1.3: Escrow Agreement
Exhibit 1.6: Assumption of Liabilities
Exhibit 1.7: Bill of Sale
Exhibit 6.6: Employment Contract
Exhibit 6.7: Non-Competition Contract
The Registrant undertakes to supply copies of the omitted Schedules and Exhibits
to the Commission upon request.
